Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with...

por Kavanaugh, A, Gladman, D, van der Heijde, D, Purcaru, O, Mease, P
Publicado 2015

Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial

por Smolen, J S, Emery, P, Ferraccioli, G F, Samborski, W, Berenbaum, F, Davies, O R, Koetse, W, Purcaru, O, Bennett, B, Burkhardt, H
Publicado 2015

Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from...

por Emery, P, Bingham, C O, Burmester, G R, Bykerk, V P, Furst, D E, Mariette, X, van der Heijde, D, van Vollenhoven, R, Arendt, C, Mountian, I, Purcaru, O, Tatla, D, VanLunen, B, Weinblatt, M E
Publicado 2017